Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis

Pharmacol Rep. 2011;63(2):305-36. doi: 10.1016/s1734-1140(11)70499-6.

Abstract

Acridine derivatives constitute a class of compounds that are being intensively studied as potential anticancer drugs. Acridines are well-known for their high cytotoxic activity; however, their clinical application is limited or even excluded because of side effects. Numerous synthetic methods are focused on the preparation of target acridine skeletons or modifications of naturally occurring compounds, such as acridone alkaloids, that exhibit promising anticancer activities. They have been examined in vitro and in vivo to test their importance for cancer treatment and to establish the mechanism of action at both the molecular and cellular level, which is necessary for the optimization of their properties so that they are suitable in chemotherapy. In this article, we review natural and synthetic acridine/acridone analogs, their application as anticancer drugs and methods for their preparation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acridines / chemical synthesis
  • Acridines / pharmacology*
  • Acridones / chemical synthesis
  • Acridones / pharmacology*
  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacology*
  • Biological Products / chemical synthesis
  • Biological Products / pharmacology
  • Drug Screening Assays, Antitumor / methods
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / physiopathology

Substances

  • Acridines
  • Acridones
  • Antineoplastic Agents
  • Biological Products